Mounjaro^® through Hims

Mounjaro® (tirzepatide) is approved by the MHRA as a treatment for weight management, when used with a reduced-calorie diet and increased physical activity. It is administered once weekly using a convenient multi-dose injectable pen. In a 72-week clinical trial, of adults with obesity or overweight and weight-related medical problems, participants taking Mounjaro® lost on average up to 22.5% of their body weight.^*

^{Source: Mounjaro patient information leaflet}

^{*Along with a reduced-calorie diet and increased exercise. Individual results may vary. Mounjaro® is a registered trade mark of Eli Lilly and Company. Hims & Hers Health, Inc. is not affiliated with or endorsed by Eli Lilly and Company.}

You can see if you’re suitable for Mounjaro® through Hims, 100% online via a consultation with a UK-registered clinician. A licensed clinician trained in weight management will review your health history, weight loss goals, and individual needs to determine if Mounjaro® through Hims is right for you. If eligible, your treatment will be delivered directly to your door, and you will have access to dynamic tools through the Care Portal.

Mounjaro® is MHRA approved for weight management along with a reduced-calorie diet and increased exercise.^*

^{*Along with a reduced-calorie diet and increased exercise. In a 72-week clinical trial of Mounjaro® (15 mg), participants with obesity or with overweight and weight-related medical problems achieved an average weight loss of 22.5%. Individual results may vary.}

Mounjaro® is a GLP-1 receptor agonist, similar to the body’s naturally-occurring GLP-1 hormone, that helps regulate appetite and metabolism by targeting both GLP-1 and GIP receptors.

^{Source: Mounjaro patient information leaflet}

Through Hims, Mounjaro® treatments start for as low as £269/month for a 12 month plan* (paid upfront, in full), if a clinician determines treatment is right for you.

^{*Plans are charged upfront. Actual cost may vary depending on the subscription programme.}

Mounjaro® is injected once a week and comes in a convenient multi-dose pen. We’ll walk you through how to safely give yourself medication with step-by-step guides and video tutorials in your Care Portal.

Mounjaro® has been evaluated and approved by the MHRA as an effective treatment for weight management when combined with diet and exercise*. You can find important safety information here.

^{*Source: Mounjaro patient information leaflet}

Both medications belong to a class of drugs known as GLP-1 receptor agonists and contain tirzepatide. Talk to a clinician to determine which treatment may be right for you*.

^{*Along with a reduced calorie diet and increased physical activity. Mounjaro® and Zepbound® are registered trade marks of Eli Lilly and Company. Hims & Hers Health, Inc. is not affiliated with or endorsed by Eli Lilly and Company.}

Mounjaro® mimics GLP-1 and GIP receptors found naturally in the body to help with weight management. Regulate appetite: Binds to receptors in your gut and brain that influence your appetite, leading to decreased calorie intake. You eat less because you’ll feel fuller for longer.

^{Source: Mounjaro patient information leaflet}

A clinician will help you start at the right dose and guide you on how to increase it over time. This gradual approach helps your body adjust to the medication while reducing side effects. As your dose increases, your price will remain the same from 2.5 mg to 7.5 mg. If you and your clinician decide to increase from 7.5 mg to 10 mg or above, you’ll move into a higher pricing tier.^*

^{*Plans are charged upfront. Actual cost may vary depending on the subscription programme.}